EUVIMEDEUVIMED entdecken
Crossref

Sepsis Diagnostic Excellence and Its Association With Mortality in Adults With Potential Infection

Marc Kowalkowski iD, Sarah Birken, Corey Obermiller, Chadwick D Miller, Jessica A Palakshappa iD, Bradley Rowland iD, Jessie King, Timothy Rogers, Shuo Tian iD, Sachita Shrestha iD, Laura Clark, Stephanie Taylor iD

Clinical Infectious Diseases · 2026

DOI: 10.1093/cid/ciag382 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Marc Kowalkowski und 11 weiteren Autor:innen. Beteiligte Einrichtung: Section of Hospital Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA. Hauptthemen laut MEDLINE: Sepsis. Die Arbeit nennt 40 Literaturangaben. Gefördert von: AHRQ HHS, Agency for Healthcare Research and Quality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diagnostic uncertainty in sepsis contributes to both undertreatment (delayed antibiotics) and overtreatment (unnecessary early antibiotics in nonsepsis patients). We hypothesized hospitals with strong sepsis undertreatment and overtreatment performance have better outcomes.

Methods

We conducted a retrospective cohort study of hospitalized adults at 20 hospitals (Advocate Health, Michigan Medicine) between 2022 and 2024. Patients met ≥2 systemic inflammatory response syndrome criteria within 6 hours of presentation. Hospital performance was characterized using risk-standardized rates (RSRs) for undertreatment and overtreatment. “Diagnostic excellence” (DxEx) was prespecified as top-tertile performance in 1 measure without bottom-tertile performance in the other. The primary outcome was hospital mortality or hospice discharge. Secondary outcomes were hospital-free days alive at 28 days (HFD), length of stay (LOS), and total antibiotic days.

Results

Among 152 779 patients, 49 109 (32.1%) received antibiotics within 3 hours and 16 361 (10.7%) ultimately met sepsis criteria. Undertreatment RSRs ranged from 29.3% to 46.8%. Overtreatment RSRs ranged from 21.5% to 37.2%. There was negative correlation between performance ranks (τ = −0.51; P = .01). Four hospitals met DxEx criteria. Receiving treatment at DxEx hospitals was associated with lower hospital mortality or hospice discharge (adjusted OR = 0.61; 95% CI = .41–.90; P = .01), greater HFD (adjusted difference = 0.59; 95% CI = .04–1.14; P = .04), reduced LOS (adjusted difference = −1.20; 95% CI = −2.23 to −.17; P = .02), and fewer antibiotic days (adjusted difference = −0.62; 95% CI = −1.28–.05; P = .07), versus non-DxEx hospitals.

Conclusions

Hospital performance that jointly minimizes sepsis undertreatment and overtreatment was associated with improved patient outcomes, adjusting for patient and hospital factors. Findings highlight the importance of reducing diagnostic error in efforts to improve sepsis outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SepsisHumansRetrospective StudiesFemaleHospital MortalityAnti-Bacterial AgentsAgedMaleMiddle AgedUndertreatmentLength of StayOvertreatmentMichiganAdultHospitalsAged, 80 and over

Stichwörter der Autor:innen

clinical decision-makingovertreatmentpatient safetysepsisundertreatment

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Section of Hospital Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
  • Center for Health System Sciences, Advocate Health, Charlotte, North Carolina, USA.
  • Department of Implementation Science, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
  • Department of Internal Medicine, Informatics and Analytics, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
  • Department of Emergency Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
  • Section of Pulmonary and Critical Care Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.

ORCID-Profile: Marc Kowalkowski, Jessica A Palakshappa, Bradley Rowland, Shuo Tian, Sachita Shrestha, Stephanie Taylor

Förderung

  • AHRQ HHS
  • Agency for Healthcare Research and Quality

Zitieren

APA

Kowalkowski, M., Birken, S., Obermiller, C., Miller, C. D., Palakshappa, J. A., Rowland, B., King, J., Rogers, T., Tian, S., Shrestha, S., Clark, L., & Taylor, S. (2026). Sepsis Diagnostic Excellence and Its Association With Mortality in Adults With Potential Infection. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag382

Vancouver

Kowalkowski M, Birken S, Obermiller C, Miller CD, Palakshappa JA, Rowland B, et al. Sepsis Diagnostic Excellence and Its Association With Mortality in Adults With Potential Infection. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag382

BibTeX
@article{Kowalkowski2026,
  author = {Kowalkowski, Marc and Birken, Sarah and Obermiller, Corey and Miller, Chadwick D and Palakshappa, Jessica A and Rowland, Bradley and King, Jessie and Rogers, Timothy and Tian, Shuo and Shrestha, Sachita and Clark, Laura and Taylor, Stephanie},
  title = {Sepsis Diagnostic Excellence and Its Association With Mortality in Adults With Potential Infection},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciag382}
}
Kostenlos starten →